However, AUY922, like other HSP90 inhibitors, strongly inhibits cell growth and also promotes apoptosis in tumor cell lines such as HT29 and HCT116, which are addicted to mitogen-activated protein kinase (MAPK) signaling mediated by RAF kinases, potentially confounding reliable measurement of protein levels. The gene discussed is WNK2; the disease is neoplasm.